Skip to main content

The timeline can be navigated by dragging the pointer on the timeline bar, located at the bottom of the screen on desktop and on the left on mobile. To filter by a specific topic, make a selection on the dropdown “Filters” menu or click “Search” to do a keyword search. To learn more, click “Read More” below.

View Full Guide

23andMe develops its own compound, and licenses it to a pharmaceutical company.

2020

MHT
PHA
GEN
EPD
CORP

The company uses their own genetic data to produce an antibody that "targets a family of proteins associated with several autoimmune and inflammatory diseases, including lupus and Crohn's disease" (Musil, 2020).

The Spanish pharmaceutical company, Almirall, is then licensed to develop and commercialize the antibody for worldwide use.